Skip to content

Effect of Magnetic Stimulation in Parkinsons Disease

Effect of Transcranial Magnetic Stimualtion on changes in Microel-Electrode Recording patterns patient with Parkinsons Disease undergoing Deep Brain Stimulation: A Randomized Sham Controlled Study. - TMS-DBS-MER

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/11/021925
Enrollment
30
Registered
2019-11-07
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G20- Parkinsons disease

Interventions

Intervention1: Real TMS: 10 Hz for 6 days Control Intervention1: Sham TMS: The settings being used during real stimulation will be mimicked minus the actual stimulation. Thus sham stimulation will be

Sponsors

ICMR
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Diagnosis of clinically definite PD, defined by UKPD brain bank clinical and diagnostic criteria. With presence of at least 1 out of 3 cardinal motor features of PD (resting tremor, rigidity, and postural impairment like bradykinesia); 2. PD patients of both gender with H&Y stage above 1 to 2. 3. PD patients between age 45 to 75 on stable medication for at least 30 days.

Exclusion criteria

Exclusion criteria: 1. Features suggestive of other causes of Parkinsonism/ Parkinson-plus syndromes; 2. History of ICSOL (intracranial space occupying lesion) or brain surgeries, significant headaches, epilepsy or seizure disorder, mass lesions, or major head trauma leading to loss of consciousness of any length; 3. Family (1st degree relatives) history of epilepsy; 4. Presence of contraindications for functional magnetic resonance imaging (fMRI) like metal implants, and claustrophobia; 5. History of schizophrenia, schizoaffective disorder, other psychosis, rapid-cycling bipolar illness, alcohol/drug abuse within the past year; 6. Need for rapid clinical response due to conditions such as psychosis, or suicide tendency; 7. Patients with uncontrolled hypertension and diabetes and other uncontrolled medical illness. Patients with hypertension or diabetes would be included only if they are stable on medication for last six months.

Design outcomes

Primary

MeasureTime frame
UPDRS, PDQ 39, LED,Timepoint: Day 1 and Day 6

Secondary

MeasureTime frame
MERTimepoint: During Scheduled DBS surgery;resting fMRITimepoint: Day 1 and Day 6

Countries

India

Contacts

Public ContactDr Vinay Goyal

AIIMS

drvinaygoyal@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026